ZTE Axon 30 5G compliant with 200MP camera, Snapdragon 888 SoC and unusual phone design

Chinese smartphone maker ZTE was recently the first brand to launch its Axon 20 Pro 5G smartphone with a sub-display selfie camera. However, they are again planning to make headlines with its Axon 30 Pro 5G, which is set to launch soon. The teaser for the handset was spotted on Weibo and posted by ZTE’s director of Customer Experience Department, Lu Qianhao.

The teaser showed a silhouette of the smartphone along with an unusual designed bar that has a large knob on the right side. According to the profiteering, the lump is said to include the cameras of the smartphone.

Interestingly, in the same post Lu Qianhao has also talked about the advantages of Qualcomm Snapdragon 888, revealing that the device will have the same SoC, along with its support for 200- megapixel. This is said to be a true idea that the upcoming handset could get a 200-megapixel sensor made by Samsung.

Read also: Another phone with a selfie camera not displayed shows up in outstretched hands on video

As mentioned by Android Central, the sensor size in the 200-megapixel camera may be smaller than the one in a 108-megapixel camera, found in the Galaxy S21 Ultra. The size of the sensor also affects the amount of light captured in each click.

While ZTE exec talks about Snapdragon 888’s lightweight image capture performance, it does suggest somewhere that the company could make up for the lack of sensor size by introducing two pixel connection modes. individually in the camera.

For those unfamiliar, smartphone cameras usually go for a four-in-one pixel approach where all four pixels are integrated into one. As it reduces the overall resolution, there will also be a brighter image as each pixel accumulates more light. Thus, in Axon 30 Pro 5G, while the camera is said to have a four-in-one pixel connection mode for 50-megapixel images, there may be an additional 16-in-1 connection mode. will produce 12.5- megapixel images but much brighter images. These are still profitable, and nothing has been proven.